Optimising outpatient care in mild to moderate psoriasis by a newly developed Topical Treatment Optimising Programme - an international study using Daivobet/Dovobet Gel (PSO-TOP)
Read time: 1 mins
Last updated:9th Dec 2011
To assess the value of the Topical Treatment Optimising Programme in the topical treatment of insufficiently treated mild to moderate psoriasis after 8 weeks of once daily treatment with Daivobet Gel.
|Study start date||2011-12-09|